How AI Enables Faster Time to Market and Stronger Regulatory Strategy for MedTech

In this webinar, QuickVault and NyquistAI will explore how AI-driven regulatory strategy is reshaping regulatory planning, from device classification and predicate identification to stronger, more informed regulatory strategy development.

Participants will learn how startups can build data-backed regulatory strategies faster, reduce reliance on costly consultants, and accelerate time to market. You’ll also hear directly from the CEO and co-founder of Phiex Technologies, a medtech sterilization company and NyquistAI customer, who will share insights about their experience navigating the regulatory process and applying these approaches in practice.

By increasing confidence in regulatory pathways and early planning, AI can help de-risk execution for founders and investors alike, enabling earlier, better-informed decisions without sacrificing regulatory rigor.

What you’ll learn:

• How to move from reactive regulatory planning to a more proactive, data-backed strategy
• Ways that AI can help uncover earlier insights that support faster and more confident decision-making
• How startups can use AI to inform classification, predicate selection, and clinical planning
• What real-world adoption looks like from a MedTech founder navigating the regulatory process
• How academic research strengthens regulatory strategy and supports more credible evidence planning
• How better early planning can help teams save time, reduce costs, and de-risk the path to market